SINGAPORE: Concessions on safe management measures will be extended to people vaccinated with Sinovac's COVID-19 vaccine when there is enough evidence to justify it, said Health Minister Ong Ye Kung in Parliament on Monday .
"The data on the efficacy of the Sinovac vaccine against the Delta variant is still building up," said Mr Ong, noting that Sinovac recently submitted the required safety data for its application for approval under the Pandemic Special Access Route.Currently, only the Pfizer-BioNTech/Comirnaty and Moderna mRNA vaccines are approved under the Pandemic Special Access Route for use in Singapore's national vaccination programme.
"The Health Sciences Authority and our expert committee are going through the various data. When the evidence justifies it, we will certainly want to extend the concessions to individuals who have received the Sinovac or other vaccines which may qualify," said Mr Ong.Authorities previously said that there will be differentiated safe management measures for people vaccinated under the national programme.
As of Jul 9, HSA received 10 reports of adverse events after vaccination with Sinovac, comprising “mainly allergic reactions such as itch and rashes”, said the Health Minister. He added that if the supply of 200,000 doses that the Government procured is insufficient to cater to the
Pfizer is only 39% effective. Don't brag too big. Sinovac is equally effective against severe covid-19 and hospitalization.
OBJECTION! THAT'S DISCRIMINATION AGAINST THOSE WHO GOT SINOVAC VACCINATION. WE SHOULD BE TREATED THE SAME AS ALL SPOREANS WHO CHOSE OUR DESIRED VACCINES.
Chances of getting covid-19 infection is higher among those vaccinated with mRNA than those without vaccination. But vaccination prevents severe illness and hospitalization. However, mutation of virus into stronger strain on those vaccinated is possible.
How about Pfizer
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: TODAYonline - 🏆 1. / 99 Read more »
Source: TODAYonline - 🏆 1. / 99 Read more »
Source: YahooSG - 🏆 3. / 71 Read more »
Source: YahooSG - 🏆 3. / 71 Read more »
Source: TODAYonline - 🏆 1. / 99 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »